Informa Exhibitions announces acquisition of Florida International Medical Exposition (FIME)
Global Life Sciences trade show operations to expand into U.S.
London, UK: Informa’s Global Exhibitions Division has announced the expansion of its Life Sciences portfolio with the acquisition of FIME Exhibition & Congress in Miami, Florida. FIME complements the Group’s existing collection of 22 exhibitions and in excess of 100 conferences across the EMEA and APAC Life Science markets.
Now in its 25th year, FIME serves the communities of North and South America with a primary focus on medical technology, medical products & supplies, medical services, and medical equipment. Under Informa’s stewardship, FIME will continue to offer a multi-speciality conference programme in line with Informa’s motto of ‘Exhibition with Education’ providing an unrivalled knowledge-sharing and business networking platform for healthcare trade professionals in the region.
Commenting on the transaction Charlie McCurdy, CEO of Informa’s Global Exhibitions Division said “The acquisition of FIME will generate substantial value for our customers and partners by driving further product innovation and deeper engagement in these specific markets. Informa has the resources as a global company to grow the show on a strategic level and we anticipate the show will become a key component of our Global Exhibitions Division.”
According to Simon Page, Managing Director, Informa Life Sciences Exhibitions: “Informa has a long-term strategic vision to continue to expand the Life Sciences’ exhibition business into the American markets. The recent acquisition of FIME fits in firmly with our goal of expanding our international trade show operations in the region and with our existing portfolio of life sciences events across the globe.”
Informa has entered new geographies effectively and built on success in existing markets. The recent acquisition of the U.S.-based Virgo Group, as well as Orlando MegaCon and Hanley Wood Exhibitions, all work towards strengthening Informa’s positions in the Americas while expanding its presence in key vertical markets.